Recommendations on bleeding and nonbleeding complications of vitamin K antagonists.
Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Jack
J
Ansell
D000925:Anticoagulants / Q000009:adverse effects*; D001728:Dicumarol / Q000009:adverse effects*; D019317:Evidence-Based Medicine; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D017410:Practice Guidelines as Topic; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D014812:Vitamin K; D001728:Dicumarol